Annual ROE
-0.81%
-1.67%-194.19%
December 1, 2023
Summary
- As of February 8, 2025, SVA annual return on equity is -0.81%, with the most recent change of -1.67% (-194.19%) on December 1, 2023.
- During the last 3 years, SVA annual ROE has fallen by -15.80% (-105.40%).
- SVA annual ROE is now -100.72% below its all-time high of 112.93%, reached on December 31, 2021.
Performance
SVA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-1.05%
-0.24%-29.63%
June 1, 2024
Summary
- As of February 8, 2025, SVA quarterly return on equity is -1.05%, with the most recent change of -0.24% (-29.63%) on June 1, 2024.
- Over the past year, SVA quarterly ROE has increased by +1.67% (+61.40%).
- SVA quarterly ROE is now -100.73% below its all-time high of 144.62%, reached on June 30, 2021.
Performance
SVA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SVA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -194.2% | +61.4% |
| 3 y3 years | -105.4% | -100.7% |
| 5 y5 years | -108.7% | -106.3% |
SVA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.7% | at low | -101.0% | +61.4% |
| 5 y | 5-year | -100.7% | at low | -100.7% | +61.4% |
| alltime | all time | -100.7% | +99.5% | -100.7% | +97.6% |
Sinovac Biotech ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -1.05%(+29.6%) |
| Dec 2023 | -0.81%(-194.2%) | -0.81%(-70.2%) |
| Jun 2023 | - | -2.72%(-423.8%) |
| Dec 2022 | 0.86%(-99.2%) | 0.84%(-97.3%) |
| Jun 2022 | - | 31.08%(-70.5%) |
| Dec 2021 | 112.93%(+653.4%) | 105.29%(-27.2%) |
| Jun 2021 | - | 144.62%(+429.5%) |
| Dec 2020 | 14.99%(+7.5%) | 27.31%(+221.3%) |
| Sep 2020 | - | 8.50%(+11.7%) |
| Jun 2020 | - | 7.61%(-43.3%) |
| Mar 2020 | - | 13.43%(-18.9%) |
| Dec 2019 | 13.95%(+50.2%) | 16.55%(+110.3%) |
| Sep 2019 | - | 7.87%(-5.5%) |
| Jun 2019 | - | 8.33%(+23.4%) |
| Mar 2019 | - | 6.75%(-35.4%) |
| Dec 2018 | 9.29%(-44.8%) | 10.45%(-28.4%) |
| Sep 2018 | - | 14.59%(+62.8%) |
| Jun 2018 | - | 8.96%(+50.8%) |
| Mar 2018 | - | 5.94%(-65.0%) |
| Dec 2017 | 16.82%(-3837.8%) | 16.97%(+166.8%) |
| Jun 2017 | - | 6.36%(-1513.3%) |
| Dec 2016 | -0.45%(-55.9%) | -0.45%(-87.7%) |
| Sep 2016 | - | -3.67%(-48.5%) |
| Jun 2016 | - | -7.12%(-562.3%) |
| Mar 2016 | - | 1.54%(-252.5%) |
| Dec 2015 | -1.02%(-3.8%) | -1.01%(+50.7%) |
| Sep 2015 | - | -0.67%(-226.4%) |
| Jun 2015 | - | 0.53%(-119.8%) |
| Mar 2015 | - | -2.68%(+150.5%) |
| Dec 2014 | -1.06%(-119.4%) | -1.07%(-140.8%) |
| Sep 2014 | - | 2.62%(-38.5%) |
| Jun 2014 | - | 4.26%(-38.9%) |
| Mar 2014 | - | 6.97%(+24.7%) |
| Dec 2013 | 5.45%(-150.4%) | 5.59%(-345.2%) |
| Sep 2013 | - | -2.28%(-63.8%) |
| Jun 2013 | - | -6.29%(-25.4%) |
| Mar 2013 | - | -8.43%(-22.3%) |
| Dec 2012 | -10.81% | -10.85%(+102.0%) |
| Sep 2012 | - | -5.37%(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | -4.69%(+81.1%) |
| Mar 2012 | - | -2.59%(+339.0%) |
| Dec 2011 | -0.58%(-92.1%) | -0.59%(-93.1%) |
| Sep 2011 | - | -8.52%(+20.9%) |
| Jun 2011 | - | -7.05%(+0.4%) |
| Mar 2011 | - | -7.02%(+20.2%) |
| Dec 2010 | -7.33%(-126.0%) | -5.84%(-181.5%) |
| Sep 2010 | - | 7.17%(-46.8%) |
| Jun 2010 | - | 13.49%(-39.1%) |
| Mar 2010 | - | 22.15%(-25.8%) |
| Dec 2009 | 28.24%(+58.3%) | 29.86%(+34.9%) |
| Sep 2009 | - | 22.14%(+41.0%) |
| Jun 2009 | - | 15.70%(+29.0%) |
| Mar 2009 | - | 12.17%(-26.5%) |
| Dec 2008 | 17.84%(-36.8%) | 16.55%(-5.7%) |
| Sep 2008 | - | 17.55%(-26.0%) |
| Jun 2008 | - | 23.73%(+1.8%) |
| Mar 2008 | - | 23.32%(-18.2%) |
| Dec 2007 | 28.23%(-932.7%) | 28.52%(+25.9%) |
| Sep 2007 | - | 22.66%(+53.9%) |
| Jun 2007 | - | 14.72%(+206.0%) |
| Mar 2007 | - | 4.81%(-168.5%) |
| Dec 2006 | -3.39%(-88.3%) | -7.02%(-35.4%) |
| Sep 2006 | - | -10.86%(-27.0%) |
| Jun 2006 | - | -14.87%(-36.1%) |
| Mar 2006 | - | -23.27%(-24.1%) |
| Dec 2005 | -28.91%(-18.1%) | -30.66%(-7.8%) |
| Sep 2005 | - | -33.24%(-5.6%) |
| Jun 2005 | - | -35.22%(-19.8%) |
| Mar 2005 | - | -43.93%(+34.8%) |
| Dec 2004 | -35.29%(+122.2%) | -32.58%(+377.0%) |
| Sep 2004 | - | -6.83%(+95.7%) |
| Jun 2004 | - | -3.49%(-118.7%) |
| Mar 2004 | - | 18.68%(-55.7%) |
| Dec 2003 | -15.88%(-90.9%) | 42.17% |
| Apr 2002 | -175.25%(-347.0%) | - |
| Apr 2001 | 70.95%(-34.2%) | - |
| Apr 2000 | 107.87%(-581.3%) | - |
| Apr 1999 | -22.41% | - |
FAQ
- What is Sinovac Biotech annual return on equity?
- What is the all time high annual ROE for Sinovac Biotech?
- What is Sinovac Biotech annual ROE year-on-year change?
- What is Sinovac Biotech quarterly return on equity?
- What is the all time high quarterly ROE for Sinovac Biotech?
- What is Sinovac Biotech quarterly ROE year-on-year change?
What is Sinovac Biotech annual return on equity?
The current annual ROE of SVA is -0.81%
What is the all time high annual ROE for Sinovac Biotech?
Sinovac Biotech all-time high annual return on equity is 112.93%
What is Sinovac Biotech annual ROE year-on-year change?
Over the past year, SVA annual return on equity has changed by -1.67% (-194.19%)
What is Sinovac Biotech quarterly return on equity?
The current quarterly ROE of SVA is -1.05%
What is the all time high quarterly ROE for Sinovac Biotech?
Sinovac Biotech all-time high quarterly return on equity is 144.62%
What is Sinovac Biotech quarterly ROE year-on-year change?
Over the past year, SVA quarterly return on equity has changed by +1.67% (+61.40%)